301 related articles for article (PubMed ID: 33298918)
21. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
22. Chromatin interaction networks revealed unique connectivity patterns of broad H3K4me3 domains and super enhancers in 3D chromatin.
Thibodeau A; Márquez EJ; Shin DG; Vera-Licona P; Ucar D
Sci Rep; 2017 Oct; 7(1):14466. PubMed ID: 29089515
[TBL] [Abstract][Full Text] [Related]
23. Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.
Carbone A; Cesarman E; Gloghini A; Drexler HG
AIDS; 2010 Feb; 24(4):479-90. PubMed ID: 20051807
[TBL] [Abstract][Full Text] [Related]
24. Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.
Franco HL; Nagari A; Malladi VS; Li W; Xi Y; Richardson D; Allton KL; Tanaka K; Li J; Murakami S; Keyomarsi K; Bedford MT; Shi X; Li W; Barton MC; Dent SYR; Kraus WL
Genome Res; 2018 Feb; 28(2):159-170. PubMed ID: 29273624
[TBL] [Abstract][Full Text] [Related]
25. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P
Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154
[TBL] [Abstract][Full Text] [Related]
26. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.
Carbone A; Gloghini A; Cozzi MR; Capello D; Steffan A; Monini P; De Marco L; Gaidano G
Br J Haematol; 2000 Oct; 111(1):247-57. PubMed ID: 11091208
[TBL] [Abstract][Full Text] [Related]
27. Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction.
Bi X; Yang L; Mancl ME; Barnes BJ
J Interferon Cytokine Res; 2011 Apr; 31(4):373-82. PubMed ID: 21133648
[TBL] [Abstract][Full Text] [Related]
28. Systematic mapping of functional enhancer-promoter connections with CRISPR interference.
Fulco CP; Munschauer M; Anyoha R; Munson G; Grossman SR; Perez EM; Kane M; Cleary B; Lander ES; Engreitz JM
Science; 2016 Nov; 354(6313):769-773. PubMed ID: 27708057
[TBL] [Abstract][Full Text] [Related]
29. Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.
Qin Z; Dai L; Trillo-Tinoco J; Senkal C; Wang W; Reske T; Bonstaff K; Del Valle L; Rodriguez P; Flemington E; Voelkel-Johnson C; Smith CD; Ogretmen B; Parsons C
Mol Cancer Ther; 2014 Jan; 13(1):154-64. PubMed ID: 24140934
[TBL] [Abstract][Full Text] [Related]
30. Connectome and regulatory hubs of CAGE highly active enhancers.
Briend M; Rufiange A; Moncla LM; Mathieu S; Bossé Y; Mathieu P
Sci Rep; 2023 Apr; 13(1):5594. PubMed ID: 37019979
[TBL] [Abstract][Full Text] [Related]
31. Enhancer RNAs: a missing regulatory layer in gene transcription.
Mao R; Wu Y; Ming Y; Xu Y; Wang S; Chen X; Wang X; Fan Y
Sci China Life Sci; 2019 Jul; 62(7):905-912. PubMed ID: 30593613
[TBL] [Abstract][Full Text] [Related]
32. Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice.
Ahmad A; Groshong JS; Matta H; Schamus S; Punj V; Robinson LJ; Gill PS; Chaudhary PM
Cancer Biol Ther; 2010 Nov; 10(10):1033-40. PubMed ID: 20818173
[TBL] [Abstract][Full Text] [Related]
33. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of a novel VEGF-producing HHV-8-unrelated PEL-like lymphoma cell line, OGU1.
Kawauchi K; Ogasawara T; Aiba M; Fujibayashi M; Sanaka T; Sakura H; Shibuya M
Eur J Haematol; 2016 Feb; 96(2):144-51. PubMed ID: 25846106
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.
Jiang S; Willox B; Zhou H; Holthaus AM; Wang A; Shi TT; Maruo S; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):421-6. PubMed ID: 24344258
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated herpesvirus.
Lubyova B; Kellum MJ; Frisancho JA; Pitha PM
J Biol Chem; 2007 Nov; 282(44):31944-53. PubMed ID: 17728244
[TBL] [Abstract][Full Text] [Related]
37. Modulation of Cellular CpG DNA Methylation by Kaposi's Sarcoma-Associated Herpesvirus.
Journo G; Tushinsky C; Shterngas A; Avital N; Eran Y; Karpuj MV; Frenkel-Morgenstern M; Shamay M
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899086
[TBL] [Abstract][Full Text] [Related]
38. Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival.
Wang C; Zhu C; Wei F; Zhang L; Mo X; Feng Y; Xu J; Yuan Z; Robertson E; Cai Q
J Virol; 2015 Oct; 89(20):10416-26. PubMed ID: 26246572
[TBL] [Abstract][Full Text] [Related]
39. High levels of LINE-1 transposable elements expressed in Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma.
Ahuja A; Journo G; Eitan R; Rubin E; Shamay M
Oncogene; 2021 Jan; 40(3):536-550. PubMed ID: 33188297
[TBL] [Abstract][Full Text] [Related]
40. Human herpesvirus-8-positive primary effusion lymphoma in HIV-negative patients: Single institution case series with a multidisciplinary characterization.
Rossi G; Cozzi I; Della Starza I; De Novi LA; De Propris MS; Gaeta A; Petrucci L; Pulsoni A; Pulvirenti F; Ascoli V
Cancer Cytopathol; 2021 Jan; 129(1):62-74. PubMed ID: 32975904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
